|Articles|October 5, 2022
SEQSTER and PatientsLikeMe Launch National Rare Disease Study
Study aims to better understand how to reduce delays in diagnosis, decrease disparities in care, and improve outcomes in patients with Alpha-1 Antitrypsin Deficiency.
Advertisement
SEQSTER and PatientsLikeMe (PLM) have collaborated to launch a rare-disease study focused on Alpha-1 Antitrypsin Deficiency (AATD). The study aims to better understand how to reduce delays in diagnosis, decrease disparities in care, and improve outcomes in patients with AATD.
Read more about the study
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
SCOPE Summit 2026 Keynote Panel: Is Radical Acceleration in Clinical Research Possible?
2
SCOPE Summit 2026 Panel Discussion: Diversity in Clinical Trials—What’s Working, What’s Next
3
Accelerate Clinical Trials with AI-Enhanced Financial Management
4
SCOPE Summit 2026 Keynote Fireside Chat: Aligning Purpose, Innovation, and Operational Excellence in Clinical Development
5